Product Code: GVR-4-68040-525-0
Healthcare Cold Chain Third Party Logistics Market Growth & Trends:
The global healthcare cold chain third party logistics market size is expected to reach USD 66.12 billion by 2030, growing at a CAGR of 7.64% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by increasing reliance on biopharmaceuticals and other temperature-sensitive products. Biopharmaceuticals require stringent temperature controls to maintain efficacy, making cold chain logistics indispensable. Moreover, the growing prevalence of chronic diseases, along with the demand for precision medicine and gene therapies, has boosted the need for reliable temperature-controlled transportation. In addition, regulatory requirements for the storage and handling of biologics further emphasize the role of specialized logistics providers in ensuring compliance and product safety.
In addition, pharmaceutical and biopharmaceutical companies are increasingly focusing on expanding into emerging markets to strengthen their market position. Emerging countries are witnessing increasing demand for high-value drugs, necessitating robust cold storage and transportation networks. This expansion is driving investments in infrastructure, including temperature-controlled warehouses and specialized transportation fleets. In addition, strategic partnerships between pharmaceutical firms and 3PL providers are becoming more common to ensure seamless global distribution.
Key market players are adopting various strategies to strengthen their position in the healthcare cold chain logistics market. These include expanding global networks, investing in cutting-edge cold storage facilities, and leveraging digital solutions for enhanced tracking and compliance. Strategic mergers, acquisitions, and partnerships are also shaping the competitive landscape, allowing companies to extend their market reach and service capabilities. In February 2024, FedExmentioned its new FedEx Life Science Center in India, which will support the clinical trial logistics & storage requirements of healthcare customers in the Indian market & those shipping to India from around the world.
Healthcare Cold Chain Third Party Logistics Market Report Highlights:
- Based on service, transportation dominated the market due to the increasing global demand for temperature-sensitive pharmaceutical products, including biologics, vaccines, and specialty drugs
- Based on the product, biopharmaceuticals held the largest market share in 2024 due to the rising demand for biologics, cell and gene therapies, and monoclonal antibodies. These temperature-sensitive products require stringent storage and transportation conditions
- Based on temperature range, frozen held the largest market share in 2024 due to stringent regulatory guidelines and compliance requirements that have pushed pharmaceutical companies to adopt advanced frozen storage and transportation solutions, ensuring product integrity
- Based on end use, pharmaceutical & biopharmaceutical companies held the largest market share in 2024 due to their high reliance on temperature-controlled storage and transportation for biologics and specialty drugs
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Service Segment
- 1.2.2. Application Segment
- 1.2.3. End Use Segment
- 1.3. Information Analysis
- 1.3.1. Market Formulation & Data Visualization
- 1.4. Data Validation & Publishing
- 1.5. Information Procurement
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.4. Industry Analysis Tools
- 3.4.1. Porter's Five Forces Analysis
- 3.4.2. PESTEL Analysis
- 3.4.3. COVID-19 Impact Analysis
Chapter 4. Healthcare Cold Chain Third Party Logistics Market: Service Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Healthcare Cold Chain Third Party Logistics Market; Service Movement Analysis
- 4.3. Healthcare Cold Chain Third Party Logistics Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
- 4.4. Transportation
- 4.4.1. Transportation market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Warehousing & Storage
- 4.5.1. Warehousing & Storage market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2. Air Freight
- 4.5.2.1. Air Freight market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.3. Sea Freight
- 4.5.3.1. Sea Freight market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.4. Overland
- 4.5.4.1. Overland market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Packaging Solutions
- 4.6.1. Packaging Solutions market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7. Monitoring & Visibility Solutions
- 4.7.1. Monitoring & Visibility Solutions market estimates and forecasts 2018 to 2030 (USD Million)
- 4.8. Inventory Management
- 4.8.1. Inventory Management market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9. Others
- 4.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Healthcare Cold Chain Third Party Logistics Market: Product Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Healthcare Cold Chain Third Party Logistics Market; Product Movement Analysis
- 5.3. Healthcare Cold Chain Third Party Logistics Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 5.4. Biopharmaceuticals
- 5.4.1. Biopharmaceuticals market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Pharmaceuticals
- 5.4.2.1. Pharmaceuticals market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Medical Device
- 5.4.3.1. Medical Device market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Others
- 5.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Healthcare Cold Chain Third Party Logistics Market: Temperature Range Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Healthcare Cold Chain Third Party Logistics Market; Temperature Range Movement Analysis
- 6.3. Healthcare Cold Chain Third Party Logistics Size & Trend Analysis, by Temperature Range, 2018 to 2030 (USD Million)
- 6.4. Frozen
- 6.4.1. Frozen market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Ultra-frozen/Deep-Frozen
- 6.4.2.1. Ultra-frozen/Deep-Frozen market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. Cryogenic
- 6.4.3.1. Cryogenic market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Healthcare Cold Chain Third Party Logistics Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Healthcare Cold Chain Third Party Logistics Market; End Use Movement Analysis
- 7.3. Healthcare Cold Chain Third Party Logistics Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 7.4. Pharmaceutical & Biopharmaceutical Companies
- 7.4.1. Pharmaceutical & Biopharmaceutical Companies market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5. Medical Device Companies
- 7.5.1. Medical Device Companies market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Others
- 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Regional Business Analysis
- 8.1. Regional Dashboard
- 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 8.3. North America
- 8.3.1. North America healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. U.S. healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.3.3. Canada
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Canada healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.3.4. Mexico
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. Mexico healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.4. Europe
- 8.4.1. Europe healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.4.2. Germany
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. Germany healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.4.3. UK
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. UK healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.4.4. France
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. France healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.4.5. Italy
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Italy healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.4.6. Spain
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Spain healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.4.7. Denmark
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. Denmark healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.4.8. Sweden
- 8.4.8.1. Key Country Dynamics
- 8.4.8.2. Competitive Scenario
- 8.4.8.3. Regulatory Framework
- 8.4.8.4. Sweden healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.4.9. Norway
- 8.4.9.1. Key Country Dynamics
- 8.4.9.2. Competitive Scenario
- 8.4.9.3. Regulatory Framework
- 8.4.9.4. Norway healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.5.2. Japan
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Japan healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.5.3. China
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. China healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.5.4. India
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competitive Scenario
- 8.5.4.3. Regulatory Framework
- 8.5.4.4. India healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.5.5. South Korea
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Competitive Scenario
- 8.5.5.3. Regulatory Framework
- 8.5.5.4. South Korea healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.5.6. Australia
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Competitive Scenario
- 8.5.6.3. Regulatory Framework
- 8.5.6.4. Australia healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.5.7. Thailand
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Competitive Scenario
- 8.5.7.3. Regulatory Framework
- 8.5.7.4. Thailand healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.6. Latin America
- 8.6.1. Latin America healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.6.2. Brazil
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. Brazil healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.6.3. Argentina
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Argentina healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.7. MEA
- 8.7.1. MEA healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.7.2. South Africa
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competitive Scenario
- 8.7.2.3. Regulatory Framework
- 8.7.2.4. South Africa healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.7.3. Saudi Arabia
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competitive Scenario
- 8.7.3.3. Regulatory Framework
- 8.7.3.4. Saudi Arabia healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.7.4. UAE
- 8.7.4.1. Key Country Dynamics
- 8.7.4.2. Competitive Scenario
- 8.7.4.3. Regulatory Framework
- 8.7.4.4. UAE healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
- 8.7.5. Kuwait
- 8.7.5.1. Key Country Dynamics
- 8.7.5.2. Competitive Scenario
- 8.7.5.3. Regulatory Framework
- 8.7.5.4. Kuwait healthcare cold chain third party logistics market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Company Market Position Analysis, 2024
- 9.3. Company Profiles
- 9.3.1. Cardinal Health
- 9.3.1.1. Company overview
- 9.3.1.2. Financial performance
- 9.3.1.3. Service benchmarking
- 9.3.1.4. Strategic initiatives
- 9.3.2. DHL
- 9.3.2.1. Company overview
- 9.3.2.2. Financial performance
- 9.3.2.3. Service benchmarking
- 9.3.2.4. Strategic initiatives
- 9.3.3. Agility
- 9.3.3.1. Company overview
- 9.3.3.2. Financial performance
- 9.3.3.3. Service benchmarking
- 9.3.3.4. Strategic initiatives
- 9.3.4. SF Express
- 9.3.4.1. Company overview
- 9.3.4.2. Financial performance
- 9.3.4.3. Service benchmarking
- 9.3.4.4. Strategic initiatives
- 9.3.5. Kinesis
- 9.3.5.1. Company overview
- 9.3.5.2. Financial performance
- 9.3.5.3. Service benchmarking
- 9.3.5.4. Strategic initiatives
- 9.3.6. UPS
- 9.3.6.1. Company overview
- 9.3.6.2. Financial performance
- 9.3.6.3. Service benchmarking
- 9.3.6.4. Strategic initiatives
- 9.3.7. Barrett Distribution Centers
- 9.3.7.1. Company overview
- 9.3.7.2. Financial performance
- 9.3.7.3. Service benchmarking
- 9.3.7.4. Strategic initiatives
- 9.3.8. AmerisourceBergen
- 9.3.8.1. Company overview
- 9.3.8.2. Financial performance
- 9.3.8.3. Service benchmarking
- 9.3.8.4. Strategic initiatives
- 9.3.9. DB Schenker
- 9.3.9.1. Company overview
- 9.3.9.2. Financial performance
- 9.3.9.3. Service benchmarking
- 9.3.9.4. Strategic initiatives
- 9.3.10. FedEx
- 9.3.10.1. Company overview
- 9.3.10.2. Financial performance
- 9.3.10.3. Service benchmarking
- 9.3.10.4. Strategic initiatives
- 9.3.11. KUEHNE + NAGEL
- 9.3.11.1. Company overview
- 9.3.11.2. Financial performance
- 9.3.11.3. Service benchmarking
- 9.3.11.4. Strategic initiatives